Archive for February, 2018

Discussion with CEOs from Inspirata and Omnyx

| February 14, 2018 | 0 Comments

In the wake of the news of Inspirata acquiring Omnyx recently I had an opportunity to speak with the CEOs of each company and get their thoughts. The big question in my mind and those of many readers was “Why Omnyx? Why now?” How did this happen? Below is a summary of our discussion. Perhaps […]

Continue Reading

Paige.AI Lands $25 Million Series A Financing and 25 Million Slides from Memorial Sloan Kettering

| February 8, 2018 | 0 Comments

25 million slides in an exclusive relationship with MSK and 25 million dollars in funding are some big numbers.  Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial intelligence (AI), recently announced two major milestones: Paige.AI signed a comprehensive license agreement with Memorial Sloan Kettering Cancer Center (MSK) to gain […]

Continue Reading

Mass Validation Study of OptraSCAN Digital Pathology Leads to Approval by Government of India

| February 7, 2018 | 0 Comments

Largest digital pathology study to date, analyzing and validating over 6600 FFPE slides, yields an approval for the use of OptraSCAN® whole slide scanners in India medical settings SUNNYVALE, CA–(BUSINESS WIRE)—OptraSCAN today announced it has successfully completed the mass validation of its whole slide digital scanner OptraSCAN® with the support of India’s Biotechnology Industry Research […]

Continue Reading

So, is the mass 17 cm or 1.7 cm?

| February 4, 2018 | 0 Comments

One of my favorite YouTube videos is entitled “Surgeon vs. Pathologist” but it could easily be “Pulmonologist” or “Gastroenterologist” or “Urologist” or more “vs. Pathologist”. Every pathologist has their own stories about these incidences and cases. The one below really happened to me years ago (parts of it are intermixed with some details of other […]

Continue Reading